"NVS" の関連情報検索結果
Novartis AG (NVS) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance

Novartis AG (NVS) Hits Fresh High: Is There Still Room to Run? Yahoo Finance
Phase III Setback: Novartis Cosentyx Falls Short in Giant Cell Arteritis Trial Results - Stock Titan

Phase III Setback: Novartis Cosentyx Falls Short in Giant Cell Arteritis Trial Results Stock Titan
Novartis (NVS) provides update on Phase III GCAptAIN study of Cosentyx in giant cell arteritis - ...

Novartis (NVS) provides update on Phase III GCAptAIN study of Cosentyx in giant cell arteritis StreetInsider
PFE, NVS, and JNJ: The Shining Stars of the Sluggish Healthcare Sector - TipRanks

PFE, NVS, and JNJ: The Shining Stars of the Sluggish Healthcare Sector TipRanks
(NVS) Technical Data - news.stocktradersdaily.com

(NVS) Technical Data news.stocktradersdaily.com
Novartis (NVS): Cosentyx Falls Short in Key Phase 3 Trial for GCA - GuruFocus

Novartis (NVS): Cosentyx Falls Short in Key Phase 3 Trial for GCA GuruFocus
Novartis fails in Phase 3 trial for Cosentyx (NVS:NYSE) - Seeking Alpha

Novartis fails in Phase 3 trial for Cosentyx (NVS:NYSE) Seeking Alpha
Novartis' Cosentyx Fails Late-Stage Giant Cell Arteritis Trial - Benzinga

Novartis' Cosentyx Fails Late-Stage Giant Cell Arteritis Trial Benzinga
Novartis (NVS) Acquires Regulus Therapeutics for $1.7 Billion - MSN

Novartis (NVS) Acquires Regulus Therapeutics for $1.7 Billion MSN
Novartis' Cosentyx Misses Primary Goal in Arteritis Phase III Study - TradingView

Novartis' Cosentyx Misses Primary Goal in Arteritis Phase III Study TradingView
NVS-02: Navigation signals from transfer orbit - GPS World

Deutsche Bank Remains a Buy on Novartis (NVS) With a CHF115 PT - Insider Monkey

Deutsche Bank Remains a Buy on Novartis (NVS) With a CHF115 PT Insider Monkey
Novartis (NVS) Reports Positive Outcomes in Phase IIIB Fabhalta Study | NVS Stock News - GuruFocus

Novartis (NVS) Reports Positive Outcomes in Phase IIIB Fabhalta Study | NVS Stock News GuruFocus
Novartis AG (NVS): A Bull Case Theory - MSN

Novartis AG (NVS) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance

Novartis AG (NVS) Hit a 52 Week High, Can the Run Continue? Yahoo Finance
Why Novartis (NVS) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Why Novartis (NVS) is a Top Momentum Stock for the Long-Term Yahoo Finance
Should Value Investors Buy Novartis (NVS) Stock? - Yahoo Finance

Should Value Investors Buy Novartis (NVS) Stock? Yahoo Finance
Here's Why Novartis (NVS) is a Strong Value Stock - Nasdaq

Here's Why Novartis (NVS) is a Strong Value Stock - Yahoo Finance

Here's Why Novartis (NVS) is a Strong Value Stock Yahoo Finance
Novartis: A SWAN Worth Owning (NYSE:NVS) - Seeking Alpha

Novartis: A SWAN Worth Owning (NYSE:NVS) Seeking Alpha
Novartis AG (NVS) Q1 2025 Earnings Call Highlights: Impressive Growth and Strategic Advancements ...

Novartis AG (NVS) Q1 2025 Earnings Call Highlights: Impressive Growth and Strategic Advancements Yahoo Finance
Novartis (NVS) Unleashes $23BN Strategic Investment Masterstroke - TipRanks

Novartis (NVS) Unleashes $23BN Strategic Investment Masterstroke TipRanks
Why Novartis (NVS) is a Great Dividend Stock Right Now - Yahoo Finance

Why Novartis (NVS) is a Great Dividend Stock Right Now Yahoo Finance
What Makes Novartis AG (NVS) a Differentiated Business? - Yahoo Finance

What Makes Novartis AG (NVS) a Differentiated Business? Yahoo Finance
Here's Why Novartis (NVS) is a Strong Momentum Stock - Yahoo Finance

Here's Why Novartis (NVS) is a Strong Momentum Stock Yahoo Finance
Novartis (NVS) Advances in Acquisition with Key Regulatory Appro - GuruFocus

Novartis (NVS) Advances in Acquisition with Key Regulatory Appro GuruFocus
Why Novartis (NVS) is a Top Dividend Stock for Your Portfolio - Yahoo Finance

Why Novartis (NVS) is a Top Dividend Stock for Your Portfolio Yahoo Finance
India Strengthens Regional Navigation with Advanced NVS-02 Satellite - Forecast International

India Strengthens Regional Navigation with Advanced NVS-02 Satellite Forecast International
Berenberg Bank Maintains a Hold Rating on Novartis (NVS) - Insider Monkey

Berenberg Bank Maintains a Hold Rating on Novartis (NVS) Insider Monkey
Novartis (NVS) Concludes Acquisition Offer for Regulus Therapeutics | NVS Stock News - GuruFocus

Novartis (NVS) Concludes Acquisition Offer for Regulus Therapeutics | NVS Stock News GuruFocus
Here's Why Novartis (NVS) is a Strong Momentum Stock - Nasdaq

Novartis (NVS) Partners with ProFound for Cardiovascular Drug De - GuruFocus

Novartis (NVS) Partners with ProFound for Cardiovascular Drug De GuruFocus
Novartis AG (NVS): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts - Yahoo Fin...

Novartis AG (NVS): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts Yahoo Finance
Novartis AG (NVS): Among the Best Undervalued Stocks to Invest In Now - Yahoo Finance

Novartis AG (NVS): Among the Best Undervalued Stocks to Invest In Now Yahoo Finance
Why Novartis (NVS) is a Top Momentum Stock for the Long-Term - Nasdaq

Why Novartis (NVS) is a Top Momentum Stock for the Long-Term Nasdaq
NVS August 15th Options Begin Trading - Nasdaq

Compared to Estimates, Novartis (NVS) Q1 Earnings: A Look at Key Metrics - Nasdaq

Compared to Estimates, Novartis (NVS) Q1 Earnings: A Look at Key Metrics Nasdaq
Novartis After Sandoz: The Business Without Generics (NYSE:NVS) - Seeking Alpha

Novartis After Sandoz: The Business Without Generics (NYSE:NVS) Seeking Alpha
Novartis (NVS) Completes Acquisition of Regulus Therapeutics | NVS Stock News - GuruFocus

Novartis (NVS) Completes Acquisition of Regulus Therapeutics | NVS Stock News GuruFocus
Novartis (NVS) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

Novartis (NVS) is a Great Momentum Stock: Should You Buy? Yahoo Finance
Novartis (NVS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Novartis (NVS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates Yahoo Finance
NVS: 3 Gene Therapy Stocks With Game-Changing Potential - StockNews

NVS: 3 Gene Therapy Stocks With Game-Changing Potential StockNews
India’s first launch of 2025 sends NVS-02 navigation satellite into orbit - SpaceNews

India’s first launch of 2025 sends NVS-02 navigation satellite into orbit SpaceNews
Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeut...

Novartis AG (NVS): Among the Best Global Stocks to Buy According to Hedge Funds - Yahoo Finance

Novartis AG (NVS): Among the Best Global Stocks to Buy According to Hedge Funds Yahoo Finance
Novartis (NVS) Surges 4.0%: Is This an Indication of Further Gains? - Nasdaq

Novartis (NVS) Surges 4.0%: Is This an Indication of Further Gains? Nasdaq
Novartis (NVS) Could Be a Great Choice - Yahoo Finance

Novartis (NVS) Could Be a Great Choice Yahoo Finance
Novartis (NVS) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

Novartis (NVS) Upgraded to Buy: What Does It Mean for the Stock? Yahoo Finance
Why Novartis AG (NVS) Is a Pharma Titan Built for the Next Decade - AInvest

Why Novartis AG (NVS) Is a Pharma Titan Built for the Next Decade AInvest
NVS Plans to Invest $23B in US Manufacturing Sites Amid Tariff Threat - TradingView

NVS Plans to Invest $23B in US Manufacturing Sites Amid Tariff Threat TradingView
NVS Named Top 10 SAFE International Dividend Stock - Nasdaq

A $100 Million Problem? ISRO’s NVS-02 Navigation Satellite Stuck in Orbit - Orbital Today

A $100 Million Problem? ISRO’s NVS-02 Navigation Satellite Stuck in Orbit Orbital Today
Pharma Stock Roundup: NVS, ABBV M&A Deals, FDA Nod to RHHBY, PFE Drugs - Yahoo Finance

Pharma Stock Roundup: NVS, ABBV M&A Deals, FDA Nod to RHHBY, PFE Drugs Yahoo Finance
FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers - Benzinga

FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers Benzinga
Should Value Investors Buy Novartis (NVS) Stock? - Nasdaq

NVS - Novartis Latest Stock News & Market Updates - Stock Titan

NVS - Novartis Latest Stock News & Market Updates Stock Titan
Novartis (NVS) Could Be a Great Choice - Nasdaq

Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure - Yahoo Finance

Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure Yahoo Finance
Enhanced scavenger-free photocatalysis-self-Fenton degradation performance over B-doped NVs modif...

Enhanced scavenger-free photocatalysis-self-Fenton degradation performance over B-doped NVs modified g-C ScienceDirect.com
Why Novartis (NVS) is a Top Value Stock for the Long-Term - Nasdaq

Why Novartis (NVS) is a Top Value Stock for the Long-Term Nasdaq
Novartis (NVS) Unveils $23B U.S. Expansion Plan To Boost Domesti - GuruFocus

Novartis (NVS) Unveils $23B U.S. Expansion Plan To Boost Domesti GuruFocus
Regulus Therapeutics (RGLS) to be Acquired by Novartis (NVS) for $7 Per Share - StreetInsider

Regulus Therapeutics (RGLS) to be Acquired by Novartis (NVS) for $7 Per Share StreetInsider
Final Trade: NVS, XLU, GM - CNBC

(NVS) Investment Analysis - news.stocktradersdaily.com

(NVS) Investment Analysis news.stocktradersdaily.com
Breakthrough: Novartis Scores Historic FDA Approval for Rare Kidney Disease Treatment - Stock Titan

Breakthrough: Novartis Scores Historic FDA Approval for Rare Kidney Disease Treatment Stock Titan
Final Trade: NVS, XLU and SMMT - CNBC

Novartis: Explaining YE24 Loss Of Momentum, Outlining Prospects For 2025 (NYSE:NVS) - Seeking Alpha

Novartis: Explaining YE24 Loss Of Momentum, Outlining Prospects For 2025 (NYSE:NVS) Seeking Alpha
As Novartis builds momentum with new drug launches, CEO says he's 'comfortable' navigating US tar...

As Novartis builds momentum with new drug launches, CEO says he's 'comfortable' navigating US tariffs Fierce Pharma
(NVS) Proactive Strategies - news.stocktradersdaily.com

(NVS) Proactive Strategies news.stocktradersdaily.com
Indian Research IRNSS-1K (NVS-02) launch Tuesday - news.satnews.com

Indian Research IRNSS-1K (NVS-02) launch Tuesday news.satnews.com
NVS vs. LLY: Which Stock Should Value Investors Buy Now? - Yahoo Finance

NVS vs. LLY: Which Stock Should Value Investors Buy Now? Yahoo Finance
Why Novartis (NVS) is a Great Dividend Stock Right Now - Nasdaq

Why Novartis (NVS) is a Great Dividend Stock Right Now Nasdaq
NVS Plans to Invest $23B in US Manufacturing Sites Amid Tariff Threat - Zacks Investment Research

NVS Plans to Invest $23B in US Manufacturing Sites Amid Tariff Threat Zacks Investment Research
Novartis AG (NYSE:NVS) Q1 2025 Earnings Call Transcript - Insider Monkey

Novartis AG (NYSE:NVS) Q1 2025 Earnings Call Transcript Insider Monkey
Novartis (NVS) Stock: Q125 Earnings Beat Boosts Confidence in Oncology and Cardio Drugs - CoinCen...

Novartis (NVS) Stock: Q125 Earnings Beat Boosts Confidence in Oncology and Cardio Drugs CoinCentral
Indian navigation satellite stranded in transfer orbit after valve malfunction - GPS World

Indian navigation satellite stranded in transfer orbit after valve malfunction GPS World
Novartis (NVS) Agrees to Acquire Regulus at a Premium Price | NV - GuruFocus

Novartis (NVS) Agrees to Acquire Regulus at a Premium Price | NV GuruFocus
Ratio Therapeutics Lands $745M Cancer Drug Development Deal with Novartis - Stock Titan

Ratio Therapeutics Lands $745M Cancer Drug Development Deal with Novartis Stock Titan
Novartis is eyeing $23B investment in U.S.(NVS:NYSE) - Seeking Alpha

Novartis is eyeing $23B investment in U.S.(NVS:NYSE) Seeking Alpha
Novartis (NVS) Boosts 2025 Outlook with Promising Growth Forecast | NVS Stock News - GuruFocus

Novartis (NVS) Boosts 2025 Outlook with Promising Growth Forecast | NVS Stock News GuruFocus
Novartis (NVS) Surges on Strong Q4 Earnings and Robust Drug Sales - GuruFocus

Novartis (NVS) Surges on Strong Q4 Earnings and Robust Drug Sales GuruFocus
ISRO Faces Setback As Its NVS-02 Satellite Thrusters Fail To Ignite In Space - Mashable India

ISRO Faces Setback As Its NVS-02 Satellite Thrusters Fail To Ignite In Space Mashable India
NV's electric vehicle industry changing under President Trump - Public News Service

NV's electric vehicle industry changing under President Trump Public News Service
Novartis AG (NVS) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Outlook ......

Novartis AG (NVS) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Outlook ... Yahoo Finance
Incyte (INCY) and Novartis (NVS) entered into settlement agreement - StreetInsider

Incyte (INCY) and Novartis (NVS) entered into settlement agreement StreetInsider
ISRO’s orbit raising operations for NVS-02 satellite disrupted by valve malfunction - The Hindu

ISRO’s orbit raising operations for NVS-02 satellite disrupted by valve malfunction The Hindu
Novartis (NVS) Reports Positive Interim Results in Prostate Canc - GuruFocus

Novartis (NVS) Reports Positive Interim Results in Prostate Canc GuruFocus
Novartis (NVS) Reports Positive Interim Results in Prostate Cancer Trial | NVS Stock News - GuruF...

Novartis (NVS) Reports Positive Interim Results in Prostate Cancer Trial | NVS Stock News GuruFocus
Glitch-hit NVS-02 can provide services only for 2-3 hours per day - Times of India

Glitch-hit NVS-02 can provide services only for 2-3 hours per day Times of India
Novartis (NVS) To Acquire Regulus Therapeutics in $0.8 Billion D - GuruFocus

Novartis (NVS) To Acquire Regulus Therapeutics in $0.8 Billion D GuruFocus
(A) Uptake of tomato fruit-derived nanovesicles (NVs) by MDCK cells... - researchgate.net

(A) Uptake of tomato fruit-derived nanovesicles (NVs) by MDCK cells... researchgate.net
Ionis stock slips as Novartis delays heart drug trial (NVS) - Seeking Alpha

Ionis stock slips as Novartis delays heart drug trial (NVS) Seeking Alpha
I heterojunction for full-spectrum catalytic organic pollutants mineralization and NO deep oxidat...

I heterojunction for full-spectrum catalytic organic pollutants mineralization and NO deep oxidation ScienceDirect.com
Novartis: 2025 Guidance Raised To Top End Of Prior Range - Buy Confirmed (NYSE:NVS) - Seeking Alpha

Novartis: 2025 Guidance Raised To Top End Of Prior Range - Buy Confirmed (NYSE:NVS) Seeking Alpha
Novartis (NVS) May 110 straddle priced into quarter results - StreetInsider

Novartis (NVS) May 110 straddle priced into quarter results StreetInsider
DFIV, SHEL, HSBC, NVS: Large Inflows Detected at ETF - Nasdaq

Top Stock Reports for Mastercard, Procter & Gamble & Novartis - Yahoo Finance

Top Stock Reports for Mastercard, Procter & Gamble & Novartis Yahoo Finance
India’s New Navigation Satellite Is Stranded in the Wrong Orbit After Thruster Glitch - Gizmodo

India’s New Navigation Satellite Is Stranded in the Wrong Orbit After Thruster Glitch Gizmodo
Down -9.72% in 4 Weeks, Here's Why You Should You Buy the Dip in Novartis (NVS) - Nasdaq

Down -9.72% in 4 Weeks, Here's Why You Should You Buy the Dip in Novartis (NVS) Nasdaq
Proposed EPA water rule could affect NV's water quality - Public News Service

Proposed EPA water rule could affect NV's water quality Public News Service